Financial statements Aether Biotech
Balance sheet data of AETHER BIOTECH
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 7 771,00 | 7 206,00 | 7 209,00 | 9 572,00 | 7 424,00 |
A. Fixed assets | 6 250,00 | 6 250,00 | 6 250,00 | 6 250,00 | 6 250,00 |
B. Current assets | 1 521,00 | 956,00 | 959,00 | 3 322,00 | 1 174,00 |
C. Share capital contributions (basic funds) | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - |
Total liabilities | 7 771,00 | 7 206,00 | 7 209,00 | 9 572,00 | 7 424,00 |
A. Equity | 3 747,00 | 4 937,00 | 3 464,00 | 2 575,00 | -1 471,00 |
B. Liabilities and provisions for liabilities | 4 024,00 | 2 269,00 | 3 745,00 | 6 997,00 | 8 895,00 |
I. Long-term liabilities | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.